The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Abstract
CONTEXT: Myeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins in atheroma, has been proposed as a possible mediator of atherosclerosis. OBJECTIVE: To determine the association between MPO levels and prevalence of coronary artery disease (CAD). DESIGN, SETTING, AND PATIENTS: Case-control study conducted from July to September 2000 in a US tertiary care referral center, including 158 patients with established CAD (cases) and 175 patients without angiographically significant CAD (controls). MAIN OUTCOME MEASURES: Association of MPO levels per milligram of neutrophil protein (leukocyte-MPO) and MPO levels per milliliter of blood (blood-MPO) with CAD risk. RESULTS: Leukocyte- and blood-MPO levels were both significantly greater in patients with CAD than in controls (P<.001). In multivariable models adjusting for traditional cardiovascular risk factors, Framingham risk score, and white blood cell counts, MPO levels were significantly associated with presence of CAD, with an OR of 11.9 (95% CI, 5.5-25.5) for the highest vs lowest quartiles of leukocyte-MPO and an OR of 20.4 (95% CI, 8.9-47.2) for the highest vs lowest quartiles of blood-MPO. CONCLUSIONS: Elevated levels of leukocyte- and blood-MPO are associated with the presence of CAD. These findings support a potential role for MPO as an inflammatory marker in CAD and may have implications for atherosclerosis diagnosis and risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Extensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by Immunohistochemistry
Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., & White, C. R. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.2.81 · Cited by 1,123
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Studies on the chlorinating activity of myeloperoxidase.
Harrison, J. E., & Schultz, J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33749-3 · Cited by 928
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
The oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Springman, E. B., Angleton, E. L., Birkedal-Hansen, H., & Van Wart, H. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.364 · Cited by 713
Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Myeloperoxidase-generated oxidants and atherosclerosis
Podrez, E. A., Abu-Soud, H. M., & Hazen, S. L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00229-x · Cited by 605
Leukocytes and the Risk of Ischemic Diseases
Ernst, E. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390170074031 · Cited by 541
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Leeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P., Oh-ishi, S., Steinbrecher, U. P., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1433 · Cited by 462
Podrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 455
Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases
Abu-Soud, H. M., & Hazen, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.48.37524 · Cited by 398
Leeuwenburgh, C., Rasmussen, J. E., Hsu, F. F., Mueller, D. M., Pennathur, S., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3520 · Cited by 361
Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins.
Heinecke, J. W., Li, W., Francis, G. A., & Goldstein, J. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116531 · Cited by 354
Savenkova, M. L., Mueller, D. M., & Heinecke, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32005-7 · Cited by 335
Increased atherosclerosis in myeloperoxidase-deficient mice
Brennan, M.-L., Anderson, M. M., Shih, D. M., Qu, X.-D., Wang, X., Mehta, A. C., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8797 · Cited by 323
Hazell, L. J., & Stocker, R. (1993) · Biochemical Journal · doi:10.1042/bj2900165 · Cited by 311
Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils.
Peppin, G. J., & Weiss, S. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4322 · Cited by 260
Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ?
Kutter, D., Devaquet, P., Vanderstocken, G., Paulus, J. M., Marchal, V., & Gothot, A. (2000) · Acta Haematologica · doi:10.1159/000041062 · Cited by 250
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
(1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370524 · Cited by 230
Hazen, S. L., Zhang, R., Shen, Z., Wu, W., Podrez, E. A., MacPherson, J. C., Schmitt, D., Mitra, S. N., Mukhopadhyay, C., Chen, Y., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.10.950 · Cited by 228
Self-citation[52] Antimicrobial activity of myeloperoxidase
Klebanoff, S. J., Waltersdorph, A. M., & Rosen, H. (1984) · Methods in Enzymology · doi:10.1016/s0076-6879(84)05055-2 · Cited by 209
Nikpoor, B., Turecki, G., Fournier, C., Théroux, P., & Rouleau, G. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116769 · Cited by 209
Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase
Abu-Soud, H. M., & Hazen, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5425 · Cited by 195
Taylor, A. J., Burke, A. P., O’Malley, P. G., Farb, A., Malcom, G. T., Smialek, J., & Virmani, R. (2000) · Circulation · doi:10.1161/01.cir.101.11.1243 · Cited by 177
The Oxidation of Lipoproteins by Monocytes-Macrophages
Chisolm, G. M., Hazen, S. L., Fox, P. L., & Cathcart, M. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.25959 · Cited by 174
Biasucci, L. M., D'Onofrio, G., Liuzzo, G., Zini, G., Monaco, C., Caligiuri, G., Tommasi, M., Rebuzzi, A. G., & Maseri, A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00524-2 · Cited by 168
Novel Risk Factors for Atherosclerosis
Kullo, I. J., Gau, G. T., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.369 · Cited by 161
Heinecke, J. W. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1113 · Cited by 140
Malle, E., Hazell, L. J., Stocker, R., Sattler, W., Esterbauer, H., & Waeg, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.982 · Cited by 136
Shabani, F., McNeil, J., & Tippett, L. (1998) · Free Radical Research · doi:10.3109/10715769809065797 · Cited by 108
Hazen, S. L., Hsu, F., & Heinecke, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1861 · Cited by 104
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R., & Frei, B. B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02227-4 · Cited by 102
Primary inherited defects in neutrophil function: etiology and treatment.
Malech, H. L., & Nauseef, W. M. (1997) · PubMed · Cited by 94
Abu‐Soud, H. M., Khassawneh, M. Y., Sohn, J., Murray, P. A., Haxhiu, M. A., & Hazen, S. L. (2001) · Biochemistry · doi:10.1021/bi011206v · Cited by 90
Schmitt, D. C., Shen, Z., Zhang, R., Colles, S. M., Wu, W., Salomon, R. G., Chen, Y., Chisolm, G. M., & Hazen, S. L. (1999) · Biochemistry · doi:10.1021/bi991623w · Cited by 89
Self-citationPodrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D. C., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574e1 · Cited by 83
Yang, C.-Y., Gu, Z., Yang, M., Lin, S., Garcia‐Prats, A. J., Rogers, L. K., Welty, S. E., & Smith, C. V. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32148-9 · Cited by 73
Heller, J. I., Crowley, J. R., Hazen, S. L., Salvay, D. M., Wagner, P. D., Pennathur, S., & Heinecke, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.9957 · Cited by 69
Hazen, S. L., Gaut, J. P., Crowley, J. R., Hsu, F., & Heinecke, J. W. (2000) · Biochemical Journal · doi:10.1042/bj3520693 · Cited by 47
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Pepe, M. S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh101 · Cited by 1,276
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Metadata
- Authors
- Zhang, R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-11-07
- Volume
- 286
- Issue
- 17
- Pages
- 2136
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2013204959
- Cited by
- 918
- References
- 47
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.